EP584 RISANZIKUMAB AS A THERAPEUTIC CHOICE FOR THE MANAGEMENT OF DIFFICULT-TO-TREAT CASES OF PYODERMA GANGRENOSUM...European Wound Management Association (EWMA) Conference, May 3-5, 2023, Milan, Italy.
Aim: Pyoderma Gangrenosum (PG) is a neutrophilic dermatosis that represents a challenge to the clinician in terms of diagnosis and treatment. Current research data are focused on the use of monoclonal antibodies (mAbs) directed against target molecules involved in the pathogenesis of PG. We reported...
| Publicado en: | Journal of Wound Management Vol. 24; no. 2; p. 367 |
|---|---|
| Autores principales: | , , , , , |
| Formato: | abstract proceedings research Journal Article |
| Publicado: |
Cambridge Publishing
Jul2023
|
| Acceso en línea: | Ver este registro en EBSCOhost |